OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections
Dana Holger, Razieh Kebriaei, Taylor Morrisette, et al.
Antibiotics (2021) Vol. 10, Iss. 5, pp. 556-556
Open Access | Times Cited: 24

Showing 24 citing articles:

Phage Therapy—Challenges, Opportunities and Future Prospects
Beata Zalewska-Piątek
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1638-1638
Open Access | Times Cited: 65

Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation
Sue C. Nang, Yu‐Wei Lin, Aleksandra Petrović Fabijan, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 6, pp. 702-709
Open Access | Times Cited: 55

Antibacterial silver nanoparticles: effects on bacterial nucleic acids
Mehran Alavi, Michael R. Hamblin
Cellular Molecular and Biomedical Reports (2023) Vol. 3, Iss. 1, pp. 35-40
Open Access | Times Cited: 29

Pseudomonas aeruginosa Bacteriophages and Their Clinical Applications
Elaheh Alipour-Khezri, Mikael Skurnik, Gholamreza Zarrini
Viruses (2024) Vol. 16, Iss. 7, pp. 1051-1051
Open Access | Times Cited: 8

Revisiting therapeutic options against Resistant Klebsiella Pneumoniae infection: phage therapy is key
Jiabao Xing, Rong-jia Han, Jinxin Zhao, et al.
Microbiological Research (2025), pp. 128083-128083
Closed Access | Times Cited: 1

Monitoring phage-induced lysis of gram-negatives in real time using a fluorescent DNA dye
Julia E. Egido, Catherine Toner-Bartelds, Ana Rita Costa, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18

Potentiation and Mechanism of Berberine as an Antibiotic Adjuvant Against Multidrug-Resistant Bacteria
Hongjuan Zhou, Wenli Wang, Long Cai, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 7313-7326
Open Access | Times Cited: 13

Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope
Mukta Kulshrestha, Monalisa Tiwari, Vishvanath Tiwari
Microbial Pathogenesis (2023) Vol. 186, pp. 106467-106467
Closed Access | Times Cited: 12

The contribution of neutrophils to bacteriophage clearance and pharmacokinetics in vivo
Arne Echterhof, Tejas Dharmaraj, Arya Khosravi, et al.
JCI Insight (2024) Vol. 9, Iss. 20
Open Access | Times Cited: 4

Invasive bacteriophages between a bell and a hammer: a comprehensive review of pharmacokinetics and bacterial defense systems
Mohammed F Hamdi, Alyaa Abdulhussein Alsaedi, Alaa Qasim Hayder, et al.
Discover Life (2025) Vol. 55, Iss. 1
Open Access

The contribution of neutrophils to bacteriophage clearance and pharmacokinetics in vivo
Arne Echterhof, Tejas Dharmaraj, Robert McBride, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

The Burden of Survivors: How Can Phage Infection Impact Non-Infected Bacteria?
Andrey V. Letarov, Maria A. Letarova
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2733-2733
Open Access | Times Cited: 6

Pharmacokinetic and Pharmacodynamic Obstacles for Phage Therapy From the Perspective of Clinical Practice
Ryszard Międzybrodzki, H Kasprzak, Sławomir Letkiewicz, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_5, pp. S395-S400
Open Access | Times Cited: 5

Effects of the combination of anti-PcrV antibody and bacteriophage therapy in a mouse model of Pseudomonas aeruginosa pneumonia
Ohara Junya, Jumpei Fujiki, Mao Kinoshita, et al.
Microbiology Spectrum (2024)
Open Access | Times Cited: 1

Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models
Amer El Ghali, Kyle Stamper, Ashlan J. Kunz Coyne, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 11
Open Access | Times Cited: 3

Bioactives from biomass: Treasure for future potent antimicrobial applications
Weicheng Chen, Peng Zhang, Yucui Ding, et al.
Chemical Engineering Journal (2024), pp. 155669-155669
Closed Access

Upsurge in Antibiotic-Resistant Infections
Sindhuprava Rana, V. Joshi, Ganesh Chandra Sahoo, et al.
(2024), pp. 25-42
Closed Access

Lytic Bacteriophages against Mutidrug-Resistant Klebsiella pneumoniae: Development of an Effective Phage-based Approach to Combat Multidrug Resistance
Willames M. B. S. Martins, Juliana Cino, Mei Li, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 2

Isolation of Pseudomonas aeruginosa Phages from Wastewaters
Stephen Chijioke Emencheta, Chinelo Charity Eze, Anthony A. Attama, et al.
Hosts and Viruses (2021) Vol. 8, Iss. 6
Open Access | Times Cited: 1

Monitoring phage-induced lysis of Gram-negatives in real time using a fluorescent DNA dye
Julia E. Egido, Catherine Toner-Bartelds, Ana Rita Costa, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top